Loading...
Last submissions
-
J.M. Hannoun-Lévi, M.-È. Chand, P. Blanchard, C. Chargari, A. Escande, et al.. Curiethérapie en France en 2020 : synthèse et perspectives du Groupe curiethérapie de la Société française de radiothérapie oncologique. Cancer/Radiothérapie, 2020, 24, pp.876 - 881. ⟨10.1016/j.canrad.2020.03.010⟩. ⟨hal-03493632⟩
-
Emmanuelle Samalin, Christelle de La Fouchardière, Simon Thèzenas, Valérie Boige, Hélène Senellart, et al.. Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27). Clinical Colorectal Cancer, 2020, ⟨10.1016/j.clcc.2020.04.008⟩. ⟨hal-02912931⟩
-
-
T. Aparicio, A. Darut-Jouve, F. Khemissa Akouz, C. Montérymard, P. Artru, et al.. Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLD. Journal of geriatric oncology, 2020, ⟨10.1016/j.jgo.2020.04.001⟩. ⟨hal-02901884⟩
-
Marie Dworczak, Marie-Cécile Le Deley, Antoine Adenis, Guillaume Piessen, Éric Lartigau, et al.. Facteurs dosimétriques liés aux complications pulmonaires postopératoires dans les cancers de l’œsophage localement avancés traités par radiochimiothérapie préopératoire : revue de la littérature. Bulletin du Cancer, 2020, 107, pp.982 - 990. ⟨10.1016/j.bulcan.2020.07.001⟩. ⟨hal-03493168⟩
-
Patrick Robelin, Michel Tod, Olivier Colomban, Joel Lachuer, Isabelle Ray-Coquard, et al.. Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study). Gynecologic Oncology, 2020, 159, pp.256 - 263. ⟨10.1016/j.ygyno.2020.07.021⟩. ⟨hal-03491450⟩
-
F. Derquin, A. Floquet, A.C. Hardy-Bessard, J. Edeline, J.P. Lotz, et al.. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network. Gynecologic Oncology, 2020, 158 (3), pp.666-672. ⟨10.1016/j.ygyno.2020.06.491⟩. ⟨hal-02909552⟩
-
-
David Pasquier, Geoffrey Martinage, Guillaume Janoray, Damaris Patricia Rojas, Dario Zerini, et al.. Salvage Stereotactic Body Radiation Therapy for Local Prostate Cancer Recurrence After Radiation Therapy A Retrospective Multicenter Study of the GETUG. International Journal of Radiation Oncology, Biology, Physics, 2019, 105 (4), pp.727-734. ⟨10.1016/j.ijrobp.2019.07.012⟩. ⟨hal-02280264⟩
-
Maud Toulmonde, Marina Pulido, Isabelle Ray-Coquard, Thierry André, Nicolas Isambert, et al.. Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study. Lancet Oncology, 2019, 20 (9), pp.1263-1272. ⟨10.1016/S1470-2045(19)30276-1⟩. ⟨hal-02533355⟩
-
-
-
G. Duhil de Bénazé, M. Vigan, N. Corradini, V. Minard-Colin, A. Marie-Cardine, et al.. Functional analysis of young patients with desmoid-type fibromatosis: Initial surveillance does not jeopardize long term quality of life. EJSO - European Journal of Surgical Oncology, 2020, 46 (7), pp.1294-1300. ⟨10.1016/j.ejso.2020.02.028⟩. ⟨hal-03477950⟩
-
C. Moreau-Bachelard, L. Campion, M. Toulmonde, A. Le Cesne, M. Brahmi, et al.. Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG). ESMO Open, 2022, 7 (2), pp.100402. ⟨10.1016/j.esmoop.2022.100402⟩. ⟨hal-03623511⟩
-
-
-
Fabien Moinard-Butot, Caroline Saint-Martin, Carole Pflumio, Matthieu Carton, William Jacot, et al.. Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort. Breast, 2022, 63, pp.54-60. ⟨10.1016/j.breast.2022.03.004⟩. ⟨hal-03647242⟩
-
-
Vincent Balaya, Benedetta Guani, Philippe Morice, Denis Querleu, Virginie Fourchotte, et al.. Long-term oncological safety of sentinel lymph node biopsy in early-stage cervical cancer: A post-hoc analysis of SENTICOL I and SENTICOL II cohorts. Gynecologic Oncology, 2022, 164 (1), pp.53-61. ⟨10.1016/j.ygyno.2021.10.074⟩. ⟨hal-03531729⟩
-
David Pasquier, Amélie Darlix, Guillaume Louvel, Julien Fraisse, William Jacot, et al.. Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort. European Journal of Cancer, 2020, 125, pp.22-30. ⟨10.1016/j.ejca.2019.11.001⟩. ⟨hal-02887998⟩